| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/28/1999 | US5958720 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 09/28/1999 | US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder |
| 09/28/1999 | US5958683 Screening method using the RZR receptor family |
| 09/28/1999 | US5958682 Virus-directed enzyme prodrug therapy for treating tumor cells consisting of a viral vector encoding bacterial nitroreductase capable of converting a prodrug into a cytotoxic drug operably linked to a promoter; and the prodrug |
| 09/28/1999 | US5958432 Cosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonists |
| 09/28/1999 | US5958427 Locally dilating blood vessels in a mammal by administering a nonpolymeric mucosally impermeant nitric oxide donor compound selected from the group of a tertiary amino or quaternary amino nitric oxide donor; male impotence, aphrodisiac |
| 09/28/1999 | US5958426 Sphingolipids and a process thereto |
| 09/28/1999 | US5958421 Cosmetic or pharmaceutical composition containing an andiroba extract |
| 09/28/1999 | US5958401 Method of using IL-11 for treating psoriasis |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/28/1999 | US5958377 Methods of delivering gases to gas-depleted environments |
| 09/28/1999 | US5957960 Internal two photon excitation device for delivery of PDT to diffuse abnormal cells |
| 09/28/1999 | CA2017029C Composition |
| 09/23/1999 | WO1999047708A1 Antisense modulation of pecam-1 |
| 09/23/1999 | WO1999047673A2 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 09/23/1999 | WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | WO1999047550A1 Novel matrix metalloproteinase inhibitors and down-regulators |
| 09/23/1999 | WO1999047549A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase) |
| 09/23/1999 | WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999047540A1 95 human secreted proteins |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047529A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 09/23/1999 | WO1999047522A1 Granulatimide derivatives for use in cancer treatment |
| 09/23/1999 | WO1999047521A1 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS |
| 09/23/1999 | WO1999047517A1 Novel heterocyclic compounds |
| 09/23/1999 | WO1999047512A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 09/23/1999 | WO1999047508A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | WO1999047505A1 Phthalazinone pde iii/iv inhibitors |
| 09/23/1999 | WO1999047501A2 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
| 09/23/1999 | WO1999047490A1 Bicyclo[2.2.1]heptanes and related compounds |
| 09/23/1999 | WO1999047173A2 Carrier for in vivo delivery of a therapeutic agent |
| 09/23/1999 | WO1999047169A1 Methods to provoke anti-cancer immune responses |
| 09/23/1999 | WO1999047158A2 Therapeutic chemokine receptor antagonists |
| 09/23/1999 | WO1999047154A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | WO1999047151A1 Peptide ligands for the erythropoietin receptor |
| 09/23/1999 | WO1999047143A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 09/23/1999 | WO1999047138A1 Statin-matrix metalloproteinase inhibitor combinations |
| 09/23/1999 | WO1999047136A1 Prevention and treatment of adhesions |
| 09/23/1999 | WO1999047134A1 Keto acid salts and amine derivatives, and their use for preparing medicines |
| 09/23/1999 | WO1999047132A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | WO1999046992A1 Induction of immunity against tumor self-antigens |
| 09/23/1999 | WO1999041374A3 Human short-chain tnf-receptor family protein |
| 09/23/1999 | WO1999040944A3 Hydroxylation activated drug release |
| 09/23/1999 | WO1999036570A3 Transglutaminase linkage of agents to tissue |
| 09/23/1999 | WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 09/23/1999 | WO1999030727A9 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 09/23/1999 | WO1999017755A3 Medicaments |
| 09/23/1999 | DE19813835A1 Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy |
| 09/23/1999 | DE19812331A1 New benzo-heterocyclic substituted piperidine derivatives useful as excitatory aminoacid receptor antagonists, used e.g. for treating neurodegenerative diseases |
| 09/23/1999 | CA2324270A1 Hypnotic .beta.-carboline derivatives, process for their preparation and their use as medicinal products |
| 09/23/1999 | CA2323784A1 Carrier for in vivo delivery of a therapeutic agent |
| 09/23/1999 | CA2323783A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | CA2323771A1 Phthalazinone pde iii/iv inhibitors |
| 09/23/1999 | CA2323761A1 95 human secreted proteins |
| 09/23/1999 | CA2323439A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | CA2323418A1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
| 09/23/1999 | CA2323083A1 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | CA2321155A1 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | CA2321113A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | CA2319493A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 09/23/1999 | CA2309588A1 Statin-matrix metalloproteinase inhibitor combinations |
| 09/23/1999 | CA2289621A1 Piperazines as inhibitors of fructose-1,6-bisphosphatase (fbpase) |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0943615A1 1,4-dihydropyridine derivatives |
| 09/22/1999 | EP0943606A1 Benzenesulfonamide derivatives and drugs containing the same |
| 09/22/1999 | EP0943334A1 Tortoise oil, turtle oil, compositions containing them, their preparation processes and uses |
| 09/22/1999 | EP0943333A1 Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis |
| 09/22/1999 | EP0943332A1 Prevention and treatment of adhesions |
| 09/22/1999 | EP0943329A1 Fluoxetine hydrochloride for decreasing hot flashes |
| 09/22/1999 | EP0943328A2 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 09/22/1999 | EP0943322A1 Use of a cosmetic composition to prevent and treat the rosacea |
| 09/22/1999 | EP0943008A1 Metal mediated serine protease inhibitors |
| 09/22/1999 | EP0942976A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942960A1 Promotion of regeneration of organized tissues |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942925A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 09/22/1999 | EP0942923A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 09/22/1999 | EP0942911A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 09/22/1999 | EP0942910A1 1,4-diazabicyclo[2.2.2]oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 09/22/1999 | EP0942906A2 Compounds useful for inhibition of farnesyl protein transferase |
| 09/22/1999 | EP0942903A1 Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| 09/22/1999 | EP0942902A2 Novel immunotherapeutic imides/amides |
| 09/22/1999 | EP0942757A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |
| 09/22/1999 | EP0942745A1 Use of hyaluronidase |
| 09/22/1999 | EP0942741A1 Lectin compositions and uses thereof |
| 09/22/1999 | EP0942740A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 09/22/1999 | EP0942735A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders |
| 09/22/1999 | EP0942732A1 Use of nk-1 receptor antagonists for treating movement disorders |
| 09/22/1999 | EP0942726A2 Use of aminopiperazine derivatives |
| 09/22/1999 | EP0942723A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 09/22/1999 | EP0942722A1 Tetrahydro-beta-carboline compounds |
| 09/22/1999 | EP0942721A1 Pharmaceutical composition |
| 09/22/1999 | EP0807086B1 Process for producing hydrotalcites |
| 09/22/1999 | EP0772615B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 09/22/1999 | EP0771324B1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |